Exelixis Inc. Common Stock vs Viavi Solutions Inc. Common Stock — how do they compare? Exelixis Inc. Common Stock trades at $59.86 (market cap $14.62B), while Viavi Solutions Inc. Common Stock trades at $45.46 (market cap $10.85B). The key difference: Exelixis Inc. Common Stock is the larger of the two by market cap, and Exelixis Inc. Common Stock is trading nearer its 52-week high, Viavi Solutions Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Exelixis Inc. Common Stock for 1 Days and Viavi Solutions Inc. Common Stock for 1 Days on average.
| EXEL | VIAV | |
|---|---|---|
Market Cap | $14.62B | $10.85B |
Volume | 2,684,957 | 4,281,289 |
Sector | Health | Technology |
52-Week High | $59.13 | $55.33 |
52-Week Low | $34.54 | $12.27 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $13.95B | $10.89B |
Trailing returns across standard periods
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →